New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
Over the past few decades, atherogenic dyslipidaemia has become one of the most common phenotypic presentations of lipid abnormalities, being strongly and unequivocally associated with an increased risk of cardiovascular (CV) disease. Despite the excellent results achieved from statin and non-statin...
Saved in:
| Main Authors: | Alberto J Lorenzatti, Peter P Toth |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-02-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2019.06 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
by: Anandita Agarwala, et al.
Published: (2020-02-01) -
Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
by: M R Essop, et al.
Published: (2023-11-01) -
Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
by: Ricardo Lopez Santi, et al.
Published: (2021-04-01) -
Association of diet quality and nutrient intake with odds of dyslipidaemia in patients with cardiovascular diseases: a hospital based cross-sectional study in Bangladesh
by: Tasmia Tasnim, et al.
Published: (2024-12-01) -
Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
by: Yu Zhang, et al.
Published: (2025-02-01)